| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |